Answers are grounded in this paper and cite their sources.
Tight BP control slows CKD progression; reinforces guidelines with updated meta-analytic support.
Background: Chronic kidney disease is a significant burden worldwide. The prevalence of chronic kidney disease (CKD) globally is 13.4% (11.7%-15.1%) for all stages. According to the National Nutrition Health Survey (NNHeS) 2003 renal report, the prevalence of CKD in the Philippines is 2.6% in CKD Stages 3–5. Kidney disease is 9th in the top ten causes of mortality according to the 2012 Philippine health statistics. High blood pressure is a major determinant of disease progression in diabetic and non diabetic chronic kidney disease. However, due to conflicting data regarding blood pressures goals, we sought to determine the effect of standard and intensive blood pressure control in all-cause mortality, cardiovascular event, renal failure, and end stage renal disease among patients with chronic kidney disease. Objective: To evaluate the effectiveness of intensive blood pressure control in reducing mortality and morbidity among patients with chronic kidney disease. Methodology: We obtained relevant trials from Pubmed and Cochrane trials. The search was restricted to studies conducted on human subjects. A review of reference list of the previous meta-analyses was also done. All prospective, randomized and clinical trials involving chronic kidney patients (CKD) with standard and intensive blood pressure control were included. Outcome measured were all cause mortality, cardiac events, end stage renal disease, and kidney injury. We obtained total of 1659 studies and ended with six studies through careful appraisal of the studies. Cochrane Review Manager Software version 5.3 was used in the analysis.
No takes yet. Share an insight, caveat, or question.
Shiu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: